Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00491543
Recruitment Status : Completed
First Posted : June 26, 2007
Last Update Posted : July 2, 2008
Information provided by:
Synvista Therapeutics, Inc